Does CILTACABTAGENE AUTOLEUCEL Cause Thrombosis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Thrombosis have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.2% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
9
Reports of Thrombosis with CILTACABTAGENE AUTOLEUCEL
0.2%
of all CILTACABTAGENE AUTOLEUCEL reports
1
Deaths
4
Hospitalizations
How Dangerous Is Thrombosis From CILTACABTAGENE AUTOLEUCEL?
Of the 9 reports, 1 (11.1%) resulted in death, 4 (44.4%) required hospitalization.
Is Thrombosis Listed in the Official Label?
Yes, Thrombosis is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Thrombosis?
LENALIDOMIDE (6,433)
APIXABAN (5,298)
RIVAROXABAN (3,220)
ADALIMUMAB (2,334)
POMALIDOMIDE (1,158)
TOFACITINIB (1,143)
RITUXIMAB (1,083)
ETANERCEPT (1,051)
METHOTREXATE (981)
PREDNISONE (963)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Thrombosis Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE